India's cold chain industry is growing at 20% annually and is estimated to be worth $8 billion, expected to reach $13 billion by 2018. Biotech and pharmaceutical industries account for less than $2 billion currently. The market is dominated by private players but is highly fragmented. In the next few years, growth will be driven by increased demand for cold storage and transportation of biotech drugs and vaccines. Challenges include a lack of standardized facilities, trained professionals and modern technologies across the fragmented supply chain. The government is promoting public-private partnerships and foreign investment to develop the industry further.